SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-042863
Filing Date
2024-02-22
Accepted
2024-02-22 16:29:47
Documents
5
Effectiveness Date
2024-02-22

Document Format Files

Seq Description Document Type Size
1 S-8 d754905ds8.htm S-8 30948
2 EX-5.1 d754905dex51.htm EX-5.1 6311
3 EX-23.1 d754905dex231.htm EX-23.1 1938
4 EX-FILING FEES d754905dexfilingfees.htm EX-FILING FEES 21250
5 GRAPHIC g754905g47w06.jpg GRAPHIC 3710
  Complete submission text file 0001193125-24-042863.txt   66725
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277274 | Film No.: 24665286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)